Skip to main content

Advertisement

ADVERTISEMENT

Radiation Protection

News
09/10/2024
iRhythm Technologies Press Release SAN FRANCISCO, Sept. 09, 2024 --  iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio® monitor, its...
iRhythm Technologies Press Release SAN FRANCISCO, Sept. 09, 2024 --  iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio® monitor, its...
iRhythm Technologies Press...
09/10/2024
EP Lab Digest
News
09/10/2024
During National Atrial Fibrillation Awareness Month, experts share advice to help patients collaborate with their healthcare provider when making decisions about care
During National Atrial Fibrillation Awareness Month, experts share advice to help patients collaborate with their healthcare provider when making decisions about care
During National Atrial...
09/10/2024
EP Lab Digest
News
09/09/2024
The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) are global leaders in science, education and transforming cardiovascular care and improving heart health for all.
The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) are global leaders in science, education and transforming cardiovascular care and improving heart health for all.
The Heart Rhythm Society (HRS)...
09/09/2024
EP Lab Digest
MEETINGS
09/06/2024
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of...
09/06/2024
Cath Lab Digest
News
09/06/2024
New Studies Highlight Enhanced Multimodal AI Analysis for Ventricular Tachycardia Mapping and Ablation
New Studies Highlight Enhanced Multimodal AI Analysis for Ventricular Tachycardia Mapping and Ablation
New Studies Highlight Enhanced...
09/06/2024
EP Lab Digest
Ahead of Print: Letter From the Editor
09/04/2024
In September 2024, the first sham-controlled AF ablation trial was published simultaneous with presentation of the study findings at the European Society of Cardiology (ESC) Congress 2024.
In September 2024, the first sham-controlled AF ablation trial was published simultaneous with presentation of the study findings at the European Society of Cardiology (ESC) Congress 2024.
In September 2024, the first...
09/04/2024
EP Lab Digest
News
09/04/2024
iRhythm Technologies Press Release iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM)...
iRhythm Technologies Press Release iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM)...
iRhythm Technologies Press...
09/04/2024
EP Lab Digest
News
09/04/2024
AliMed Press Release  Dedham, Mass. – Sept. 3, 2024 – AliMed, Inc., a Massachusetts-based medical supply manufacturer and distributor, has been awarded a contract for its radiation protection products with Vizient, the nation’s...
AliMed Press Release  Dedham, Mass. – Sept. 3, 2024 – AliMed, Inc., a Massachusetts-based medical supply manufacturer and distributor, has been awarded a contract for its radiation protection products with Vizient, the nation’s...
AliMed Press...
09/04/2024
EP Lab Digest
News
09/03/2024
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Asundexian 50 mg daily was...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as...
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as...
European Society of...
09/03/2024
EP Lab Digest

Advertisement

Advertisement

Advertisement